Evidence map›Paper›PMID 33846483›Full record

ArticleScientific reports2021

Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery.

Davide Lazzeroni, Luca Moderato, P L Marazzi, Carmen Pellegrino, Elisa Musiari, Paolo Castiglioni, Umberto Camaiora, Matteo Bini, Simone Geroldi, Lorenzo Brambilla and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Davide LazzeroniIRCCS Fondazione Don Carlo Gnocchi, Milan, Italy. davide.lazzeroni@gmail.com.
Luca ModeratoGuglielmo da Saliceto Hospital, Piacenza, Italy.
P L MarazziFondazione Don Carlo Gnocchi, Parma, Italy.
Carmen PellegrinoFondazione Don Carlo Gnocchi, Parma, Italy.
Elisa MusiariFondazione Don Carlo Gnocchi, Parma, Italy.
Paolo CastiglioniIRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.
Umberto CamaioraFondazione Don Carlo Gnocchi, Parma, Italy.
Matteo BiniFondazione Don Carlo Gnocchi, Parma, Italy.
Simone GeroldiFondazione Don Carlo Gnocchi, Parma, Italy.
Lorenzo BrambillaIRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.
Valerio BrambillaFondazione Don Carlo Gnocchi, Parma, Italy.
Paolo CoruzziDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Don Carlo Gnocchi Foundation · ITGuglielmo da Saliceto Hospital · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The red blood cell distribution width (RDW) measures the variability in the size of circulating erythrocytes. Previous studies suggested a powerful correlation between RDW obtained from a standard complete blood count and cardiovascular diseases in both primary and secondary cardiovascular prevention. The current study aimed to evaluate the prognostic role of RDW in patients undergoing cardiac rehabilitation after myocardial revascularization and/or cardiac valve surgery. The study included 1.031 patients with available RDW levels, prospectively followed for a mean of 4.5 ± 3.5 years. The mean age was 68 ± 12 years, the mean RDW was 14.7 ± 1.8%; 492 patients (48%) underwent cardiac rehabilitation after myocardial revascularization, 371 (36%) after cardiac valve surgery, 102 (10%) after valve-plus-coronary artery by-pass graft surgery, 66 (6%) for other indications. Kaplan-Meier analysis and Cox hazard analysis were used to associate RDW with mortality. Kaplan-Meier analysis demonstrated worse survival curves free from overall (log-rank p < 0.0001) and cardiovascular (log-rank p < 0.0001) mortality in the highest RDW tertile. Cox analysis showed RDW levels correlated significantly with the probability of overall (HR 1.26; 95% CI 1.19-1.32; p < 0.001) and cardiovascular (HR 1.31; 95% CI 1.23-1.40; p < 0.001) mortality. After multiple adjustments for cardiovascular risk factors, hemoglobin, hematocrit, C-reactive protein, microalbuminuria, atrial fibrillation, glomerular filtration rate,left ventricular ejection fraction and number of exercise training sessions attended, the increased risk of overall (HR 1.10; 95% CI 1.01-1.27; p = 0.039) and cardiovascular (HR 1.13; 95% CI 1.01-1.34; p = 0.036)mortality with increasing RDW values remained significant. The RDW represents an independent predictor of overall and cardiovascular mortality in secondary cardiovascular prevention patients undergoing cardiac rehabilitation.

Indexed as

AgedBiomarkersCardiac Surgical ProceduresCardiovascular DiseasesErythrocytesFemaleHumansMaleMiddle AgedMyocardial RevascularizationPrognosisProspective StudiesRisk FactorsBiomarkers

Identifiers

PMID33846483
PMCPMC8041885
OpenAlexW3155440407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.